動脈硬化:治療薬の治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Arteriosclerosis Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Arteriosclerosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Arteriosclerosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Arteriosclerosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Arteriosclerosis 25
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Arteriosclerosis Therapeutics Clinical Trials 34
Prominent Drugs 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Merck & Co., Inc. 36
Clinical Trial Overview of Merck & Co., Inc. 36
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
F. Hoffmann-La Roche Ltd. 46
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 46
Sanofi 47
Clinical Trial Overview of Sanofi 47
Bristol-Myers Squibb Company 48
Clinical Trial Overview of Bristol-Myers Squibb Company 48
Eli Lilly and Company 49
Clinical Trial Overview of Eli Lilly and Company 49
Daiichi Sankyo Company, Limited 50
Clinical Trial Overview of Daiichi Sankyo Company, Limited 50
Clinical Trial Overview of Top Institutes / Government 51
National Heart, Lung, and Blood Institute 51
Clinical Trial Overview of National Heart, Lung, and Blood Institute 51
Brigham and Women’s Hospital 57
Clinical Trial Overview of Brigham and Women’s Hospital 57
Korea University 58
Clinical Trial Overview of Korea University 58
Johns Hopkins University 59
Clinical Trial Overview of Johns Hopkins University 59
National Institute on Aging 60
Clinical Trial Overview of National Institute on Aging 60
Mayo Clinic 61
Clinical Trial Overview of Mayo Clinic 61
Tehran University of Medical Sciences 62
Clinical Trial Overview of Tehran University of Medical Sciences 62
National Defense Medical College 63
Clinical Trial Overview of National Defense Medical College 63
University of California, San Francisco 64
Clinical Trial Overview of University of California, San Francisco 64
Maastricht University Medical Center 65
Clinical Trial Overview of Maastricht University Medical Center 65
Five Key Clinical Profiles 66
Appendix 132
Abbreviations 132
Definitions 132
Research Methodology 133
Secondary Research 133
About GlobalData 134
Contact Us 134
Disclaimer 134
Source 134


【レポート販売概要】

■ タイトル:動脈硬化:治療薬の治験動向(2014年下半期)
■ 英文:Arteriosclerosis Global Clinical Trials Review, H2, 2014
■ 発行日:2014年8月12日
■ 調査会社:GlobalData
■ 商品コード:GDHC2300CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。